Literature DB >> 15778958

The incidence of congenital cytomegalovirus infections in The Netherlands.

Michael A Gaytant1, Jochem M D Galama, Ben A Semmekrot, Willem J G Melchers, Jan M M Sporken, Herman P Oosterbaan, Peter A van Dop, Aad Huisman, Hans M W M Merkus, Eric A P Steegers.   

Abstract

Cytomegalovirus (CMV) is one of the most common causes of congenital infection without an effective treatment or an effective vaccine available to date. The emphasis has to be on preventive strategies, which rely on the epidemiological situation. The incidence of congenital CMV infections, however, is not known for The Netherlands. Therefore, a prospective virological study was carried out in a population of 7,524 pregnant women and 7,793 newborns. CMV-specific IgG antibodies were determined in cord blood by ELISA. When CMV antibodies were present, a CMV specific PCR was performed on the throat swab. A positive PCR was confirmed by urine culture. In addition, the seroepidemiology for CMV was investigated in the metropolitan region (Amsterdam and Rotterdam) which has a different ethnic composition. Congenital CMV infection was found in 7 infants (0.9 per 1,000). None had symptoms at birth or during 24 month follow-up. Carriage or CMV was 41%, with a variation between 35% and 100% depending on ethnicity. The ethnic composition in the south-eastern region was different from that in large cities, but similar to that in the rest of the country. The incidence of congenital CMV infections in The Netherlands is the lowest described to date, which does not justify special preventive policies. Copyright 2005 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15778958     DOI: 10.1002/jmv.20325

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  17 in total

1.  Cytomegalovirus (CMV) seroprevalence in pregnant women, bone marrow donors and adolescents in Germany, 1996-2010.

Authors:  Gisela Enders; Anja Daiminger; Lisa Lindemann; Frank Knotek; Ursula Bäder; Simone Exler; Martin Enders
Journal:  Med Microbiol Immunol       Date:  2012-03-08       Impact factor: 3.402

2.  Incidence of cytomegalovirus infection in Shanghai, China.

Authors:  Feng-Qin Fang; Qi-Shi Fan; Zhi-Jun Yang; Yi-Bing Peng; Li Zhang; Ke-Zi Mao; Yue Zhang; Yu-Hua Ji
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

3.  Congenital cytomegalovirus infection in high-risk Canadian infants: Report of a pilot screening study.

Authors:  Wendy Vaudry; Rhonda J Rosychuk; Bonita E Lee; Po Yin Cheung; Xl Pang; Jutta K Preiksaitis
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

4.  Occupational risk of human Cytomegalovirus and Parvovirus B19 infection in female day care personnel in the Netherlands; a study based on seroprevalence.

Authors:  F F Stelma; A Smismans; V J Goossens; C A Bruggeman; C J P A Hoebe
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-10-11       Impact factor: 3.267

5.  Increased seroprevalence of IgG-class antibodies against cytomegalovirus, parvovirus B19, and varicella-zoster virus in women working in child day care.

Authors:  Gini G C van Rijckevorsel; Lian P M J Bovée; Marjolein Damen; Gerard J B Sonder; Maarten F Schim van der Loeff; Anneke van den Hoek
Journal:  BMC Public Health       Date:  2012-06-22       Impact factor: 3.295

6.  Observational study to assess pregnant women's knowledge and behaviour to prevent toxoplasmosis, listeriosis and cytomegalovirus.

Authors:  Monique T R Pereboom; Judith Manniën; Evelien R Spelten; François G Schellevis; Eileen K Hutton
Journal:  BMC Pregnancy Childbirth       Date:  2013-04-30       Impact factor: 3.007

7.  Changing patterns of cytomegalovirus seroprevalence among pregnant women in Norway between 1995 and 2009 examined in the Norwegian Mother and Child Cohort Study and two cohorts from Sor-Trondelag County: a cross-sectional study.

Authors:  Maria Lisa Odland; Kristin M Strand; Svein Arne Nordbø; Siri Forsmo; Rigmor Austgulen; Ann-Charlotte Iversen
Journal:  BMJ Open       Date:  2013-09-27       Impact factor: 2.692

8.  Latent cytomegalovirus infection is an independent risk factor for late graft failure in renal transplant recipients.

Authors:  Rutger M van Ree; Aiko P J de Vries; Dorien M Zelle; Laura V de Vries; Leendert H Oterdoom; Reinold O B Gans; Jan P Schouten; Simon P M Lems; Willem J van Son; Stephan J L Bakker
Journal:  Med Sci Monit       Date:  2011-11

9.  Impact of socioeconomic risk factors on the seroprevalence of cytomegalovirus infections in a cohort of pregnant Polish women between 2010 and 2011.

Authors:  W Wujcicka; Z Gaj; J Wilczyński; W Sobala; E Spiewak; D Nowakowska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-06-06       Impact factor: 3.267

10.  Risk factors for and clinical outcome of congenital cytomegalovirus infection in a peri-urban West-African birth cohort.

Authors:  Marianne A B van der Sande; Steve Kaye; David J C Miles; Pauline Waight; David J Jeffries; Olubukola O Ojuola; Melba Palmero; Margaret Pinder; Jamila Ismaili; Katie L Flanagan; Akum A Aveika; Akram Zaman; Sarah Rowland-Jones; Samuel J McConkey; Hilton C Whittle; Arnaud Marchant
Journal:  PLoS One       Date:  2007-06-06       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.